中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 10
Oct.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(10): 1929-1932

Research advances in traditional Chinese medicine syndromes of fatty liver disease

DOI: 10.12449/JCH241001
  • 1.

    Fouth Clinical Medical College，Guangzhou University of Chinese Medicine，Shenzhen，Guangdong 518022

  • 2.

    Center of Integrated Traditional Chinese and Western Medicine，Beijing YouAn Hospital，Capital Medical University，Beijing 100069，China

More Information
  • Corresponding author: LI Xiuhui， lixiuhui@sohu.com （ORCID： 0000-0002-6707-1693）
  • Received Date: 2024-07-23
  • Accepted Date: 2024-08-11
  • Published Date: 2024-10-25
    Abstract
  • Fatty liver disease can be classified into alcoholic fatty liver disease and nonalcoholic fatty liver disease based on etiology， and it has become the most important liver disease worldwide. Due to the differences in the etiology and pathological mechanism of fatty liver disease， it may manifest as different traditional Chinese medicine syndromes during different pathological stages. The syndrome is based on the pathogenesis in a certain stage and is the basis for syndrome differentiation in traditional Chinese medicine. At present， there is still a lack of unified studies on the syndrome of fatty liver disease， and different methods for syndrome differentiation have obtained different syndrome types， which affects the syndrome differentiation-based treatment in clinical practice. This article briefly introduces the clinical studies on the syndrome types of fatty liver disease conducted by doctors of all dynasties and modern doctors and further emphasizes the significance of standard and accurate determination of the traditional Chinese medicine syndrome types of fatty liver disease in syndrome differentiation-based treatment.

     

    • FullText(HTML)
  • loading
    • References(18)
  • [1]
    HENRY L, PAIK J, YOUNOSSI ZM. Review article: The epidemiologic burden of non-alcoholic fatty liver disease across the world[J]. Aliment Pharmacol Ther, 2022, 56( 6): 942- 956. DOI: 10.1111/apt.17158.
    [2]
    ZHU WF. TCM diagnostics[M]. Beijing: China Traditional Chinese Medicine Press, 2003.

    朱文锋. 中医诊断学[M]. 北京: 中国中医药出版社, 2003.
    [3]
    LIANG W. Study on TCM syndrome differentiation of alcoholic liver disease[D]. Nanjing: Nanjing University of Chinese Medicine, 2013.

    梁卫. 酒精性肝病的中医辨证规律研究[D]. 南京: 南京中医药大学, 2013.
    [4]
    LIANG W, WU CY. Treatment of alcoholic liver disease[J]. J Tradit Chin Med, 2013, 54( 5): 433- 434. DOI: 10.13288/j.11-2166/ r.2013.05.018.

    梁卫, 吴承玉. 酒精性肝病辨治心得[J]. 中医杂志, 2013, 54( 5): 433- 434. DOI: 10.13288/j.11-2166/r.2013.05.018.
    [5]
    Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Common understanding on Chinese medicine diagnosis and treatment of nonalcoholic fatty liver disease[J]. J Beijing Univ Tradit Chin Med, 2011, 30( 2): 83- 86.

    中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗共识意见[J]. 北京中医药, 2011, 30( 2): 83- 86.
    [6]
    Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease(2017)[J]. J Clin Hepatol, 2017, 33( 12): 2270- 2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002.

    中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识意见(2017)[J]. 临床肝胆病杂志, 2017, 33( 12): 2270- 2274. DOI: 10.3969/j.issn.1001-5256.2017.12.002.
    [7]
    Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Traditional Chinese Medicine diagnosis and treatment guidelines for nonalcoholic fatty liver disease(primary doctor edition)[J]. Chin J Integr Tradit West Med Liver Dis, 2019, 29( 5): Insert 3-Insert 6.

    中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗指南(基层医生版)[J]. 中西医结合肝病杂志, 2019, 29( 5): 后插3-后插6.
    [8]
    Diagnosis and Treatment Center of Hepatology of South China Alliance of TCM, National Administration of Traditional Chinese Medicine. Diagnosis and treatment scheme of Ganpi(non-alcoholic steatohepatitis)[J/CD]. Chin J Liver Dis Electron Version, 2021, 13( 1): 1- 9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.

    国家中医药管理局华南区中医肝病诊疗中心联盟. 肝癖(非酒精性脂肪性肝炎)诊疗方案[J/CD]. 中国肝脏病杂志(电子版), 2021, 13( 1): 1- 9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.
    [9]
    Branch of Hepatobiliary Diseases, China Association of Chinese Medicine. Diagnosis and treatment guideline for Chinese Medicine on non-alcoholic steatohepatitis[J]. J Clin Hepatol, 2023, 39( 5): 1041- 1048. DOI: 10.3969/j.issn.1001-5256.2023.05.007.

    中华中医药学会肝胆病分会. 非酒精性脂肪性肝炎中医诊疗指南[J]. 临床肝胆病杂志, 2023, 39( 5): 1041- 1048. DOI: 10.3969/j.issn.1001-5256.2023.05.007.
    [10]
    LIU XY, MA SP, ZHANG LH, et al. Professor Zhao Wenxia’s experience in treating non-alcoholic fatty liver disease with“four discriminations” and“four differentiations”[J]. Chin J Integr Tradit West Med Liver Dis, 2022, 32( 11): 964- 968. DOI: 10.3969/j.issn.1005-0264.2022.011.002.

    刘晓彦, 马素平, 张丽慧, 等. 赵文霞教授“四辨”“四分”论治非酒精性脂肪性肝病经验[J]. 中西医结合肝病杂志, 2022, 32( 11): 964- 968. DOI: 10.3969/j.issn.1005-0264.2022.011.002.
    [11]
    SUN YL, SUN JG, ZHANG Y, et al. YIN Changjian’s experience in treating nonalcoholic fatty liver disease by stages[J]. Shandong J Tradit Chin Med, 2022, 8( 5): 465- 469. DOI: 10.16295/j.cnki.0257-358x.2022.05.001.

    孙玉莉, 孙建光, 张永, 等. 尹常健分期辨治非酒精性脂肪性肝病经验[J]. 山东中医杂志, 2022, 8( 5): 465- 469. DOI: 10.16295/j.cnki.0257-358x.2022.05.001.
    [12]
    NIE ZY, FENG CL, PAN WY, et al. Feng Chonglian’s experience in the syndrome differentiation and treat-ment of non-alcoholic fatty liver disease[J]. China Med Her, 2021, 18( 22): 145- 148.

    聂钊源, 冯崇廉, 潘伟钰, 等. 冯崇廉辨治非酒精性脂肪性肝病经验探讨[J]. 中国医药导报, 2021, 18( 22): 145- 148.
    [13]
    LI XP, HAO JM, ZHAO J. Professor Yang Zhen’s experience in treating alcoholic liver disease from‘damp-heat fire’[J]. Hebei J Tradit Chin Med, 2021, 7( 2): 189- 192. DOI: 10.3969/j.issn.1002-2619.2021.02.003.

    李小平, 郝建梅, 赵晶. 杨震教授从“湿热相火”论治酒精性肝病经验[J]. 河北中医, 2021, 7( 2): 189- 192. DOI: 10.3969/j.issn.1002-2619.2021.02.003.
    [14]
    FANG LH, GUO ZL, ZHANG YF, et al. Prof.Tian Delu’s experience of three-phase three-Zang organ differentia-tion with the diagnosis and treatment of alcoholic liver disease[J]. Mod Chin Clin Med, 2021, 28( 5): 38- 42. DOI: 10.3969/j.issn.2095-6606.2021.05.009.

    方俐晖, 郭志玲, 张轶斐, 等. 田德禄教授三期三脏辨治酒精性肝病经验[J]. 现代中医临床, 2021, 28( 5): 38- 42. DOI: 10.3969/j.issn.2095-6606.2021.05.009.
    [15]
    LI XJ, ZHAO Y, FENG Q, et al. Traditional Chinese medicine syndrome types of nonalcoholic fatty liver disease based on literature data mining[J]. World Chin Med, 2023, 18( 2): 263- 268. DOI: 10.3969/j.issn.1673-7202.2023.02.020.

    李晓静, 赵瑜, 冯琴, 等. 基于文献分析的非酒精性脂肪肝中医证型分布特点[J]. 世界中医药, 2023, 18( 2): 263- 268. DOI: 10.3969/j.issn.1673-7202.2023.02.020.
    [16]
    SONG WX. Research on clinical experience of famous Traditional Chinese Medicine in treating fatty liver based on data mining[D]. Nanning: Guangxi University of Traditional Chinese Medicine, 2024.

    宋文选. 基于数据挖掘的名老中医治疗脂肪肝临床经验研究[D]. 南宁: 广西中医药大学, 2024.
    [17]
    ZHANG HZ. Analysis of TCM syndrome types based on TCM syndrome elements professor Lu Bingjiu’s essentials of treating alcoholic liver disease[D]. Shenyang: Liaoning University of Traditional Chinese Medicine, 2019.

    张慧珍. 基于中医证素证型研究探析卢秉久教授治疗酒精性肝病精要[D]. 沈阳: 辽宁中医药大学, 2019.
    [18]
    National Medical Products Administration(NMPA). Supplementary provisions on the administration of registration of Traditional Chinese Medicine[EB/OL].( 2008-01-07)[ 2023-10-06]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20080107120001991.html. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20080107120001991.html

    国家药品监督管理局. 中药注册管理补充规定[EB/OL].( 2008-01-07)[ 2023-10-06]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20080107120001991.html. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20080107120001991.html
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1582) PDF downloads(83) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return